IL2 and osteosarcoma: One more example used zoledronate, tested for use in osteosarcoma as an antitumor drug, but the efficacy was very low [97], though use with IL-2 reportedly stimulated γδ T-cells in an orthotopic mouse model of osteosarcoma.